ACA Premiums Could Increase as Much as 20%
The Society of Actuaries has estimated that premiums for the Affordable Care Act’s plans could increase by 10% to 20%. Bloomberg BNA reported that premiums could increase more, and additional insurers could exit some markets, if the cost-sharing reduction subsidies are not funded. State deadlines for filing rates vary, but there is a federal deadline of June 21 for some filings. Insurers who file rates will have until the fall to decide whether or not they will ultimately participate in the exchanges for 2018.
Cherokee Nation Files Suit Against Drug Distributors
A lawsuit filed in tribal court accuses drug distributors and pharmacies of the devastation caused by addictive pain pills that flooded into Oklahoma. According to The Washington Post, the suit says the 6 defendants named turned a “blind eye” to the situation of pain pills being diverted to the black market. The defendants named were McKesson, Cardinal Health, AmerisourceBergen, CVS, Walgreens, and Walmart. The attorney general for the Cherokees said these companies should have known they were sending too many pills to realistically only be used for “legitimate medical purposes.”
FDA Warns Against Codeine and Tramadol for Children
After identifying more than 70 cases of serious breathing problems, the FDA has expanded safety warnings for codeine and tramadol products to treat pain or relieve cough in children. Included in the cases were 27 deaths. Most of the side effects linked to the medications occurred in children younger than age 12, and sometimes 1 dose was all that was needed, reported The Wall Street Journal. The FDA is now warning neither drug should be used in children younger than 12 and that tramadol shouldn’t be used in patients younger than 18 after tonsil- or adenoid-removal surgery. Breast-feeding mothers should also not take these medications.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
2 Commerce Drive
Cranbury, NJ 08512